Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
25%
Ph phase_4
2
17%
Ph not_applicable
7
58%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 3Large-scale testing
3(25.0%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
7(58.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(8)
Other(2)

Detailed Status

Completed8
unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (25.0%)
Phase 42 (16.7%)
N/A7 (58.3%)

Trials by Status

recruiting18%
completed867%
unknown217%
not_yet_recruiting18%

Recent Activity

1 active trials
Showing 5 of 12
not_yet_recruitingnot_applicable

Zinc Supplementation and Inflammation in Older Medical Patients

NCT07672132
recruitingnot_applicable

EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients

NCT06075134
completedphase_3

Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.

NCT05465434
completednot_applicable

Zinc Supplement Before or With Food in Generally Healthy Men

NCT03619421
completednot_applicable

Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause

NCT03672513
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07672132Not Applicable

Zinc Supplementation and Inflammation in Older Medical Patients

Not Yet Recruiting
NCT06075134Not Applicable

EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients

Recruiting
NCT05465434Phase 3

Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.

Completed
NCT03619421Not Applicable

Zinc Supplement Before or With Food in Generally Healthy Men

Completed
NCT03672513Not Applicable

Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause

Completed
NCT02126293Phase 3

Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant

Completed
NCT01546805Not Applicable

Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm

Unknown
NCT01306097Not Applicable

Zinc Supplementation and Severe and Recurrent Diarrhea

Completed
NCT01101217Not Applicable

Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients

Completed
NCT00944723Phase 4

Impact of Mass Zinc Fortification Programs on Plasma Zinc Concentration

Completed
NCT00944398Phase 4

Impact of Targeted Zinc Fortification Programs on Plasma Zinc Concentration

Completed
NCT00698386Phase 3

Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients

Unknown

All 12 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
12